BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38039101)

  • 21. [Necrolytic migratory erythema in a patient with a glucagonoma].
    Demirbas M; Prens B
    Ned Tijdschr Geneeskd; 2021 Oct; 165():. PubMed ID: 34854628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucagonoma syndrome associated with necrolytic migratory erythema.
    Cardoso Filho Fde A; Feitosa RG; Fechine CO; Matos CM; Cardoso AL; Cardoso DL
    Rev Assoc Med Bras (1992); 2015; 61(3):203-6. PubMed ID: 26248239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rare presentation of endocrine pancreatic tumour: a case of glucagonoma without necrolytic migratory erythema?
    Manes G; Pellegrini A; Riccardi F; Uomo G
    Ital J Gastroenterol; 1995 Jun; 27(5):248-9. PubMed ID: 8541575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Image Gallery: Necrolytic migratory erythema associated with glucagonoma.
    Aragón-Miguel R; Prieto-Barrios M; Calleja-Algarra A; Pinilla-Martin B; Rodriguez-Peralto J; Ortiz-Romero P; Rivera-Diaz R
    Br J Dermatol; 2019 Jan; 180(1):e1. PubMed ID: 30604550
    [No Abstract]   [Full Text] [Related]  

  • 25. Necrolytic migratory erythema associated with a metastatic neuroendocrine tumor.
    Lolis MS; Krishtul A; Vidal C; Shim-Chang H; Phelps R; Lebwohl M
    Cutis; 2011 Feb; 87(2):78-80. PubMed ID: 21416773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emergency pancreatic resection for glucagonoma associated with severe necrolytic migratory erythema.
    Daly DM; Thompson B; Low J; Slater J; Wood G; Kamath V; Haghighi KS
    ANZ J Surg; 2019 May; 89(5):599-602. PubMed ID: 28982222
    [No Abstract]   [Full Text] [Related]  

  • 27. Glucagonoma syndrome with atypical necrolytic migratory erythema.
    He S; Zeng W; Geng S; Jia J
    Indian J Dermatol Venereol Leprol; 2021; 87(1):49-53. PubMed ID: 31368453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dermatitis, glossitis, stomatitis, cheilitis, anemia and weight loss: a classic presentation of pancreatic glucagonoma.
    Povoski SP; Zaman SA; Ducatman BS; McFadden DW
    W V Med J; 2002; 98(1):12-4. PubMed ID: 11941895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Glucagonoma: a recent series of 7 cases].
    Vauleon E; Egreteau J; Boucher E; Desfourneaux V; Bretagne JF; Raoul JL
    Bull Cancer; 2004; 91(7-8):637-40. PubMed ID: 15381454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Necrolytic migratory erythema: first symptom of a glucagonoma. A case report.
    Du Jardin P; Cools P; Van der Stighelen Y
    Acta Chir Belg; 2004 Aug; 104(4):468-70. PubMed ID: 15469167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Necrolytic cutaneous erythema and pancreatic tumour: the glucagonoma].
    Drematcheff S; Champetier de Ribes TL; Marty C; Sans N; Railhac JJ
    J Radiol; 2004 Mar; 85(3):329-31. PubMed ID: 15192527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucagonoma syndrome: a case report.
    Shyr YM; Su CH; Lee CH; Wu CW; Lui WY
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Sep; 62(9):639-43. PubMed ID: 10502856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Necrolytic Migratory Erythema: Complete Healing after Surgical Removal of Pancreatic Carcinoma.
    V'lckova-Laskoska M; Balabanova-Stefanova M; Arsovska-Bezhoska I; Caca-Biljanovska N; Laskoski D
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):329-332. PubMed ID: 30665484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucagonoma syndrome with serous oligocystic adenoma: A rare case report.
    Gao Y; Wang C; Gao Y; Chen H; Peng B; Chen W; Ran X
    Medicine (Baltimore); 2017 Oct; 96(43):e8448. PubMed ID: 29069049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Necrolytic migratory erythema and pancreatic glucagonoma.
    Rodríguez G; Vargas E; Abaúnza C; Cáceres S
    Biomedica; 2016 Jun; 36(2):176-81. PubMed ID: 27622478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Facial edema and erythroderma in a 54 year-old woman].
    Mourguet M; Lajaunie R; Schouler M; Godart M; Bonnet D; Riffaud L; Lamant L; Alric L; Rossi B
    Rev Med Interne; 2020 Mar; 41(3):210-213. PubMed ID: 31987672
    [No Abstract]   [Full Text] [Related]  

  • 37. Glucagonoma-related necrolytic migratory erythema.
    Bosch-Amate X; Riera-Monroig J; Iranzo Fernández P
    Med Clin (Barc); 2020 Nov; 155(9):418-419. PubMed ID: 31515063
    [No Abstract]   [Full Text] [Related]  

  • 38. [Glucagonoma without glucagonoma syndrome].
    Colović R; Matić S; Micev M; Grubor N; Latincić S
    Srp Arh Celok Lek; 2010; 138(3-4):244-7. PubMed ID: 20499510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucagonoma syndrome: a review and update on treatment.
    John AM; Schwartz RA
    J Eur Acad Dermatol Venereol; 2016 Dec; 30(12):2016-2022. PubMed ID: 27422767
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.